Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Formation of transformed endothelial cells in the absence of VEGFR-2/Flk-1 by Polyoma middle T oncogene

Abstract

The middle T antigen of murine Polyomavirus (PymT) rapidly transforms endothelial cells leading to vascular malformations reminiscent of endothelial tumors or hemangiomas. Flk-1, a receptor tyrosine kinase which is activated upon binding of its ligand VEGF, is predominantly expressed in endothelial cells and essential for the formation of blood vessels since absence of Flk-1 prevents the development of mature endothelial cells in mice and in ES-cell differentiation experiments. To investigate the role of Flk-1 in PymT-induced vascular tumor formation, we studied the expression of Flk-1 and VEGF in PymT-transformed endothelial cells (Endothelioma cells, END. cells). The receptor and its ligand were both expressed in END. cells suggesting that a VEGF/Flk-1 autocrine loop might be causally involved in the formation of vascular tumors. To test this hypothesis, ES cells lacking Flk-1 were generated and the transforming potential of PymT was analysed after in vitro differentiation. Flk-1−/− END. cell lines were established which are morphologically identical to flk-1+/+ END. cells and which express several markers characteristic for endothelial cells. This result suggests that PymT functionally replaces the requirement of Flk-1 in expansion and/or survival of endothelial progenitor cells. Therefore, flk-1−/− END. cells provide a powerful tool to dissect the downstream signaling pathways of Flk-1.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 6
Figure 5
Figure 7

Similar content being viewed by others

References

  • Bronson R, Dawe C, Carroll J and Benjamin T. . 1997 Proc. Natl. Acad. Sci. USA 94: 7954–7958.

  • Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W and Nagy A. . 1996 Nature 380: 435–439.

  • Chang HW, Aoki M, Fruman D, Auger KB, Bellacosa A, Tsichlis PN, Cantley LC, Roberts TM and Vogt PK. . 1997 Science 276: 1848–1850.

  • Choi K, Kennedy M, Kazarov A, Papadimitriou JC and Keller G. . 1998 Development 125: 725–732.

  • Christofori G, Naik P and Hanahan D. . 1995 Mol. Endocrin. 9: 1760–1770.

  • Dilworth SM. . 1995 Trends Microbiol. 3: 31–35.

  • DiMaio D, Lai CC and Klein O. . 1998 Annu. Rev. Microbiol. 52: 397–421.

  • Dubois-Stringfellow N, Kolpack-Martindale L, Bautch VL and Azizkhan RG. . 1994 Am. J. Pathol. 144: 796–806.

  • Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan KJ and Moore MW. . 1996 Nature 380: 439–442.

  • Fong GH, Rossant J, Gertsenstein M and Breitman ML. . 1995 Nature 376: 66–70.

  • Glenn GM and Eckhart W. . 1995 J. Virol. 69: 3729–3736.

  • Gotsch U, Borges E, Bosse R, Boggemeyer E, Simon M, Mossman H and Vestweber D. . 1997 J. Cell. Sci. 110: 583–588.

  • Gu H, Marth JD, Orban PC, Mossmann H and Rajewsky K. . 1994 Science 265: 103–106.

  • Gualandris A, Rusnati M, Belleri M, Nelli EE, Bastaki M, Molinari-Tosatti MP, Bonardi F, Parolini S, Albini A, Morbidelli L, Ziche M, Corallini A, Possati L, Vacca A, Ribatti D and Presta M. . 1996 Cell Growth Differ. 7: 147–160.

  • Hanahan D. . 1997 Science 277: 48–50.

  • Hashimoto M, Ohsawa M, Ohnishi A, Naka N, Hirota S, Kitamura Y and Aozasa K. . 1995 Lab. Invest. 73: 859–863.

  • Hatzopoulos AK, Folkman J, Vasile E, Eiselen GK and Rosenberg RD. . 1998 Development 125: 1457–1468.

  • Hilberg F and Wagner EF. . 1992 Oncogene 7: 2371–2380.

  • Hiratsuka S, Minowa O, Kuno J, Noda T and Shibuya M. . 1998 Proc. Natl. Acad. Sci. USA 95: 9349–9354.

  • Jeltsch M, Kaipainen A, Joukov V, Meng X, Lakso M, Rauvala H, Swartz M, Fukumura D, Jain RK and Alitalo K. . 1997 Science 276: 1423–1425.

  • Jones CL and Kane MA. . 1996 Curr. Opin. Oncol. 8: 54–59.

  • Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N and Alitalo K. . 1996 EMBO J. 15: 290–298.

  • Kaipainen A, Korhonen J, Mustonen T, van Hinsbergh VW, Fang GH, Dumont D, Breitman M and Alitalo K. . 1995 Proc. Natl. Acad. Sci. USA 92: 3566–3570.

  • Kaipainen A, Korhonen J, Pajusola K, Aprelikova O, Persico MG, Terman BI and Alitalo K. . 1993 J. Exp. Med. 178: 2077–2088.

  • Keller G, Kennedy M, Papayannopoulou T and Wiles MV. . 1993 Mol. Cell. Biol. 13: 473–486.

  • Keller GM. . 1995 Curr. Opin. Cell Biol. 7: 862–869.

  • Kiefer F, Courtneidge SA and Wagner EF. . 1994a Adv. Cancer Res. 64: 125–157.

  • Kiefer F, Anhauser I, Soriano P, Aguzzi A, Courtneidge SA and Wagner EF. . 1994b Curr. Biol. 4: 100–109.

  • Korpelainen EI and Alitalo K. . 1998 Curr. Opin. Cell Biol. 10: 159–164.

  • Laemmli UK. . 1970 Nature 227: 680–685.

  • Lampugnani MG, Resnati M, Raiteri M, Pigott R, Pisacane A, Houen G, Ruco LP and Dejana E. . 1992 J. Cell Biol. 118: 1511–1522.

  • Masood R, Cai J, Zheng T, Smith DL, Naidu Y and Gill PS. . 1997 Proc. Natl. Acad. Sci. USA 94: 979–984.

  • Millauer B, Wizigmann-Voos S, Schnurch H, Martinez R, Moller NP, Risau W and Ullrich A. . 1993 Cell 72: 835–846.

  • Montesano R, Pepper MS, Mohle-Steinlein U, Risau W, Wagner EF and Orci L. . 1990 Cell 62: 435–445.

  • Morgenstern JP and Land H. . 1990 Nucleic Acids Res. 18: 3587–3596.

  • Neufeld G, Cohen T, Gengrinovitch S and Poltorak Z. . 1999 FASEB J. 13: 9–22.

  • Pepper MS, Tacchini-Cottier F, Sabapathy TK, Montesano R and Wagner EF. . 1997 In: Tumour Angiogenesis. Bicknell R, Lewis CE and Ferrara N. (eds).. Oxford University Press: Oxford pp. 309–331.

    Google Scholar 

  • Rak J, Mitsuhashi Y, Bayko L, Filmus J, Shirasawa S, Sasazuki T and Kerbel RS. . 1995 Cancer Res. 55: 4575–4580.

  • Risau W. . 1997 Nature 386: 671–674.

  • Robertson E, Bradley A, Kuehn M and Evans M. . 1986 Nature 323: 445–448.

  • Sabapathy KT, Pepper MS, Kiefer F, Mohle-Steinlein U, Tacchini-Cottier F, Fetka I, Breier G, Risau W, Carmeliet P, Montesano R and Wagner EF. . 1997 J. Cell Biol. 137: 953–963.

  • Sauer B and Henderson N. . 1988 Proc. Natl. Acad. Sci. USA 85: 5166–5170.

  • Schuh AC, Faloon P, Hu QL, Bhimani M and Choi K. . 1999 Proc. Natl. Acad. Sci. USA 96: 2159–2164.

  • Seetharam L, Gotoh N, Maru Y, Neufeld G, Yamaguchi S and Shibuya M. . 1995 Oncogene 10: 135–147.

  • Seghezzi G, Patel S, Ren CJ, Gualandris A, Pintucci G, Robbins ES, Shapiro RL, Galloway AC, Rifkin DB and Mignatti P. . 1998 J. Cell Biol. 141: 1659–1673.

  • Shalaby F, Ho J, Stanford WL, Fischer KD, Schuh AC, Schwartz L, Bernstein A and Rossant J. . 1997 Cell 89: 981–990.

  • Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML and Schuh AC. . 1995 Nature 376: 62–66.

  • Sporn MB and Roberts AB. . 1985 Nature 313: 745–747.

  • Urbanek P, Wang ZQ, Fetka I, Wagner EF and Busslinger M. . 1994 Cell 79: 901–912.

  • Vecchi A, Garlanda C, Lampugnani MG, Resnati M, Matteucci C, Stoppacciaro A, Schnurch H, Risau W, Ruco L, Mantovani A, et al. 1994 Eur. J. Cell Biol. 63: 247–254.

  • Vittet D, Prandini MH, Berthier R, Schweitzer A, Martin-Sisteron H, Uzan G and Dejana E. . 1996 Blood 88: 3424–3431.

  • Wagner EF and Risau W. . 1994 Semin. Cancer Biol. 5: 137–145.

  • Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M and Heldin CH. . 1994 J. Biol. Chem. 269: 26988–26995.

  • Wilks AF, Kurban RR, Hovens CM and Ralph SJ. . 1989 Gene 85: 67–74.

  • Wizigmann-Voos S, Breier G, Risau W and Plate KH. . 1995 Cancer Res. 55: 1358–1364.

  • Xie Y and Muller WA. . 1993 Proc. Natl. Acad. Sci. USA 90: 5569–5573.

  • Young AT, Dahl J, Hausdorff SF, Bauer PH, Birnbaum MJ and Benjamin TL. . 1995 Proc. Natl. Acad. Sci. USA 92: 11613–11617.

Download references

Acknowledgements

We thank Drs E Ogris and A Ullrich for the generous gift of antibodies; I Mudrak for help with PymT Western blot analysis; Dr P Steinlein for help with FACScan analysis and N Howells for assistance with the tumor induction experiments. We are grateful to Drs FK Kiefer, K Matsuo and MS Pepper for critical reading of the manuscript and helpful comments. Photographic work was done by H Tkadletz. U Mühlner was a recipient of a Boehringer Ingelheim Fonds postgraduate fellowship and part of this work was supported by the Austrian Industrial Research Promotion Fund.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mühlner, U., Möhle-Steinlein, U., Wizigmann-Voos, S. et al. Formation of transformed endothelial cells in the absence of VEGFR-2/Flk-1 by Polyoma middle T oncogene. Oncogene 18, 4200–4210 (1999). https://doi.org/10.1038/sj.onc.1203014

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203014

Keywords

This article is cited by

Search

Quick links